Latest Biotech News

The FDA approved KalVista Pharmaceuticals’ sebetralstat for hereditary angioedema, representing a vital new therapeutic option for rare swelling disorders. Meanwhile, the agency faces deepening...

Cogent Biosciences announced that its phase 3 trial for bezuclastinib in indolent systemic mastocytosis met the primary endpoint, positioning the drug for potential FDA approval. The compound...

The Novo Nordisk Foundation awarded $109 million to the University of Copenhagen to establish a Center for Protein Design (CPD), aiming to become a European leader in synthetic protein...

Columbia University’s STAR AI system detected 44 sperm cells in male infertility samples previously deemed sterile by manual embryologist review. By adapting astrophysics star-detection...

Researchers at Karolinska Institutet provided direct evidence of ongoing neurogenesis in the adult human hippocampus, identifying proliferating neural progenitor cells through single-nucleus RNA...

The 'Trial Trailblazers' podcast offers an inside look at groundbreaking clinical research across diverse therapeutic areas, including rare pediatric diseases, Alzheimer's natural killer cell...

Vienna's biotech sector grew to €22.7 billion in 2023, driven by advances in research, innovation, and workforce expansion, positioning the city as a burgeoning life sciences hub. Concurrently,...

Microsoft is accelerating digital innovation in rural hospitals by addressing cybersecurity challenges and promoting AI adoption with discounted tools, training, and an innovation lab. The...

Apogee Therapeutics has announced promising midstage clinical trial results for APG777, its experimental long-acting antibody therapy targeting atopic dermatitis. The trial demonstrated that...

The FDA is experiencing a significant loss of experienced personnel amid low morale and heightened political interference. Following a reduction of 19% of its workforce coinciding with the...

A regulatory chill is emerging as the FDA signals tighter controls on clinical trials that transfer Americans’ cells to China for genetic engineering before reinfusion. Provoked by biosecurity...

Columbia University’s STAR (Sperm Tracking and Recovery) platform applied astrophysics-derived algorithms to identify sperm cells missed by conventional microscopy in samples deemed sterile....

Novartis announced that its blockbuster drug Cosentyx failed to outperform placebo in a Phase 3 study targeting giant cell arteritis, an autoimmune blood vessel disorder. The antibody therapy was...

The European Commission concluded its investigation into Alchem, fining the drugmaker for involvement in an anti-competitive cartel regarding active pharmaceutical ingredients (APIs) spanning over...

Researchers have identified fibroblast growth factor 13 (FGF13) as a critical molecule in preserving neuronal integrity within the inner ear, potentially delaying or halting hearing decline linked...

A pioneering diagnostic approach utilizing DNA methylation markers derived from bilateral nasal swabs offers a noninvasive, automated method to detect nasopharyngeal carcinoma (NPC) at early...

New research identifying molecular biomarkers predictive of radiosensitivity in adult gliomas aims to refine radiotherapy strategies for these aggressive brain tumors. Given glioma’s notorious...

Microsoft is expanding its commitment to rural healthcare by providing discounted cybersecurity tools, free digital training, and establishing an AI innovation lab accessible to over 700 rural...

The Food and Drug Administration (FDA) is struggling with a significant loss of experienced staff and declining morale, factors that threaten to undermine its regulatory effectiveness. Since April...

Rising political tensions between the U.S. and China have prompted the FDA to implement stricter regulatory measures affecting Chinese-developed drug investments and clinical trials. The agency...